SARS-CoV-2 ORF7a anticorps (AA 16-111)
-
- Antigène Tous les produits SARS-CoV-2 ORF7a
- SARS-CoV-2 ORF7a
-
Épitope
- AA 16-111
- Reactivité
- SARS Coronavirus (SARS-CoV)
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp SARS-CoV-2 ORF7a est non-conjugé
- Application
- Western Blotting (WB), Immunofluorescence (IF), Immunocytochemistry (ICC)
- Réactivité croisée
- SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)
- Purification
- Affinity purified by Protein G.
- Immunogène
- The immunogen used to generate this antibody corresponds to SARS-CoV ORF7a protein (16-111 a.a.).
- Clone
- 3C9
- Isotype
- IgG1
-
-
- Indications d'application
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Commentaires
-
Positive Control: ORF7a-transfected 293T cell
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PBS, No Preservative
- Agent conservateur
- Without preservative
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- Antigène
- SARS-CoV-2 ORF7a
- Abstract
- SARS-CoV-2 ORF7a Produits
- Synonymes
- anticorps ORF7a protein, anticorps ORF7a
- Sujet
- 2019-nCoV ORF7a , SARS-coV-2 ORF7a , COVID-19 ORF7a
-